<DOC>
	<DOCNO>NCT00925496</DOCNO>
	<brief_summary>Overall study design : This study prospective , non-randomized , multicenter postmarket clinical follow-up study two study arm use two shoulder prosthesis PROMOS™ STANDARD ( group A ) PROMOS REVERSE™ ( group B ) . The study collect efficacy safety data 10 year .</brief_summary>
	<brief_title>Patient Benefit From New Modular Shoulder Prosthesis PROMOS</brief_title>
	<detailed_description>Primary objective study : The primary objective quantify patient benefit primary total shoulder arthroplasty modular PROMOS™ shoulder system multicenter cohort study ( real world approach ) . Patient benefit quantify use objective validated subjective measure function , activity daily live ( ADL ) quality life ( QoL ) . Secondary objective : - Rate implant relate finding like radiological loosening glenoid complication like intraoperative stem fissure - Prosthesis survival common time point , e.g . 5 10 year</detailed_description>
	<criteria>Eligibility : Ages eligible study : minimal age 18 year Genders eligible study : Accepts healthy volunteer : Primary secondary omarthrosis indication primary total shoulder arthroplasty Massive rotator cuff rupture Willing able give write informed consent participate study include followup Previous ipsilateral shoulder arthroplasty ( group A B ) Late stage rotator cuff disease ( group A ) Acute shoulder trauma ( group A B ) General medical contraindication surgery ( group A B ) Legal incompetence ( group A B ) Tumour / malignoma ( group A B ) Recent history substance abuse ( group A B ) Any disease process would preclude accurate evaluation ( e.g . neuromuscular , psychiatric metabolic disorder ) ( group A B ) Known hypersensitivity material use ( group A B ) Bacterial infection time point operation ( group A B )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Omarthrosis shoulder joint</keyword>
</DOC>